Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06483334 |
| Title | A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04) |
| Acronym | MK-3475-04C/KEYMAKER-U04 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | ITA | ISR | GBR | FRA | ESP | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California San Francisco HDFCCC ( Site 4044) | San Francisco | California | 94158 | United States | Details | |
| University of Chicago Medical Center ( Site 4037) | Chicago | Illinois | 60637 | United States | Details | |
| Indiana University Melvin and Bren Simon Cancer Center ( Site 4011) | Indianapolis | Indiana | 46202 | United States | Details | |
| Dana-Farber Cancer Institute ( Site 4047) | Boston | Massachusetts | 02115 | United States | Details | |
| Siteman Cancer Center ( Site 4038) | St Louis | Missouri | 63108 | United States | Details | |
| Icahn School of Medicine at Mount Sinai ( Site 4018) | New York | New York | 10029 | United States | Details | |
| Cleveland Clinic-Taussig Cancer Center ( Site 4036) | Cleveland | Ohio | 44195 | United States | Details | |
| Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 4041) | Salt Lake City | Utah | 84112 | United States | Details | |
| The Ottawa Hospital - General Campus ( Site 4105) | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| Princess Margaret Cancer Centre ( Site 4106) | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Centre Hospitalier Lyon Sud ( Site 4606) | Pierre-Bénite | Auvergne-Rhône-Alpes | 69310 | France | Details | |
| Rambam Health Care Campus ( Site 4501) | Haifa | 3109601 | Israel | Details | ||
| Rabin Medical Center-Oncology ( Site 4504) | Petah Tikva | 4941492 | Israel | Details | ||
| Sheba Medical Center-ONCOLOGY ( Site 4503) | Ramat Gan | 5265601 | Israel | Details | ||
| Ospedale San Raffaele-Oncologia Medica ( Site 4403) | Milan | Lombardy | 20132 | Italy | Details | |
| Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 4405) | Milan | 20133 | Italy | Details | ||
| Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 4406) | Napoli | 80131 | Italy | Details | ||
| Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 4302) | Amsterdam | North Holland | 1066 CX | Netherlands | Details | |
| Severance Hospital, Yonsei University Health System-Medical oncology ( Site 4903) | Seoul | 03722 | South Korea | Details | ||
| Asan Medical Center-Department of Oncology ( Site 4901) | Seoul | 05505 | South Korea | Details | ||
| Samsung Medical Center ( Site 4902) | Seoul | 06351 | South Korea | Details | ||
| Hospital Universitari Vall d'Hebron-Oncology ( Site 4767) | Barcelona | 08035 | Spain | Details | ||
| Hospital Clinico San Carlos ( Site 4765) | Madrid | 28040 | Spain | Details | ||
| National Cheng Kung University Hospital-Clinical Trial Center ( Site 4803) | Tainan | 704 | Taiwan | Details | ||
| St Bartholomew s Hospital ( Site 4206) | London | London, City of | EC1A 7BE | United Kingdom | Details |